SUMMARY
The research of Rick J. Bold, M.D., M.B.A., focuses on developing new methods to diagnose and treat pancreatic cancer. Dr. Bold also evaluates financial and clinical outcomes of cancer care delivery in healthcare model systems.
Focus areas
- Therapies for pancreatic cancer. Dr. Bold conducts preclinical and clinical investigations characterizing the molecular genetics of pancreatic cancer. His long-term goal is to develop new therapies.
- Pancreatic cancer outcomes and policy. Dr. Bold evaluates perioperative factors that impact operative outcomes in pancreatic cancer. Such factors include patient and disease variables that relate to long-term disease-based outcomes. As part of this work, he examines system- and financial-level outcomes to guide policy for optimal models of cancer care delivery.
- Cancer detection and diagnosis. Dr. Bold studies methods to improve cancer detection and diagnosis. He has a specific interest in applying emerging technologies in the operating room for optimal patient outcomes.
Significance to patient care
The overall goal of Dr. Bold's research is to improve the outcomes of surgeries to remove cancer. This research affects care at an individual level by improving imaging of patients' cancers before surgery, developing and using better methods in the operating room, and choosing the best types of surgeries for different patients.
Dr. Bold's research also improves care at the level of healthcare systems. His results help show which characteristics lead to the best outcomes for patients. At the same time, his research helps healthcare systems put their resources to best use, with special consideration for the cost of cancer care delivery.
Professional highlights
- Emeritus professor, University of California, Davis, 2023-present.
- Site director, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic in Arizona, 2023-present.
- Member, senior editorial board, Scientific Reports, 2019-present.
- Chair, various Specialized Programs of Research Excellence (SPORE) study sections, National Institutes of Health, 2017-present.